JPS61291525A - Food for preventing allergy and adult disease and produced from rengyo and/or related species thereof - Google Patents

Food for preventing allergy and adult disease and produced from rengyo and/or related species thereof

Info

Publication number
JPS61291525A
JPS61291525A JP60133784A JP13378485A JPS61291525A JP S61291525 A JPS61291525 A JP S61291525A JP 60133784 A JP60133784 A JP 60133784A JP 13378485 A JP13378485 A JP 13378485A JP S61291525 A JPS61291525 A JP S61291525A
Authority
JP
Japan
Prior art keywords
forsythia
food
related species
extract
allergy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60133784A
Other languages
Japanese (ja)
Inventor
Yoshiyuki Kimura
善行 木村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Chemical Laboratory Co Ltd
Original Assignee
Osaka Chemical Laboratory Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osaka Chemical Laboratory Co Ltd filed Critical Osaka Chemical Laboratory Co Ltd
Priority to JP60133784A priority Critical patent/JPS61291525A/en
Publication of JPS61291525A publication Critical patent/JPS61291525A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain a food for preventing allegy and adult diseases, capable of preventing allergy and adult diseases such as thrembosis at the same time, and takable easily as a food, by using RENGYO (Forsythia supensa Vahl) or its related species as an essential component. CONSTITUTION:The objective food for preventing allergy and adult diseases can be produced by using RENGYO or its related species as an essential component. Preferably, the dried powder, extract or concentrated extract of the fruit of RENGYO or the purified product of formula I or formula II is used in the form of cake, refreshing drink, staple food, powder, etc. The simultaneous effective prevention of allergy and adult diseases such as thrombosis, which could not be attained heretofore, can be carried out by the use of the present food.

Description

【発明の詳細な説明】 (産業上の利用分野) この発明はレンギヨウ及び/又はこの近縁種を原料とす
るアレルギー及び成人病予防食品に関し、その目的は、
アレルギー及び成人病を同時に予防することができるレ
ンギヨウ及び/又はこの近縁種を原料とするアレルギー
及び成人病予防食品の提供にある。
Detailed Description of the Invention (Field of Industrial Application) The present invention relates to a food for preventing allergies and adult diseases made from Forsythia and/or its related species, and its purpose is to
To provide an allergy and adult disease preventive food made from forsythia and/or its closely related species, which can prevent allergies and adult diseases at the same time.

(従来技術とその欠点) 一般にアレルギー反応とは生体内に、異種蛋白等がとり
こまれて生体反応である抗原抗体反応が起こるとその結
果生体内の化学伝達物質であるヒスタミン、アセチルコ
リン、ブラディキニン、5R5−Aなどが遊離され、こ
れが組織を障害して起こる生体内反応であると解されて
いる。
(Prior art and its drawbacks) In general, an allergic reaction is when a foreign protein, etc. is taken into a living body and an antigen-antibody reaction occurs, which is a biological reaction. 5R5-A and the like are released, and this is understood to be an in vivo reaction that damages tissues.

従って、アレルギー反応を抑制するためにはアレルギー
反応の原因の一つである5RS−Aの前駆物質である5
−HETHの産出を阻害すればよく、この5−HETE
はアラキドン酸のりポキシゲナーゼ代謝物であるゆえ5
−HETEを特異的に阻害するものは、抗アレルギー効
果に高いと考えられている。
Therefore, in order to suppress allergic reactions, it is necessary to use 5RS-A, a precursor of 5RS-A, which is one of the causes of allergic reactions.
-HETH production can be inhibited, and this 5-HETE
is an arachidonic acid glue poxygenase metabolite, so 5
-Those that specifically inhibit HETE are considered to have high anti-allergic effects.

また、成人病の一種である血栓症とは血管内皮の損傷、
炎症、血液流の変化、血液凝固能の元通に等によってお
こる血管内で血小板が凝集して、血液が固まる症状をい
う。
In addition, thrombosis, a type of adult disease, is caused by damage to the vascular endothelium.
A condition in which platelets aggregate in blood vessels and blood clots due to inflammation, changes in blood flow, restoration of blood coagulation ability, etc.

この症状は前記アラキドン酸の代謝物であるTXBz、
 HITの増加によって、増長されるもので、このTX
B2 、HHTは前記アラキドン酸の血小板酵素シクロ
オキシゲナーゼによる代謝物ある。
This symptom is caused by TXBz, a metabolite of arachidonic acid,
This is increased by the increase in HIT, and this TX
B2, HHT is a metabolite of the arachidonic acid produced by the platelet enzyme cyclooxygenase.

また、白血球酵素シクロオキシゲナーゼによってPGI
2が生産される。このPGI2はTXA2(TXB2)
と拮抗して血栓症の予防、血小板凝集抑制作用を持つ。
In addition, PGI is activated by the leukocyte enzyme cyclooxygenase.
2 will be produced. This PGI2 is TXA2 (TXB2)
It has an antagonistic effect on preventing thrombosis and inhibiting platelet aggregation.

つまり、アラキドン酸は酵素シクロオキシゲナーゼによ
る代謝系と酵素リポキシゲナーゼによる代謝系の2代謝
系があり、又この代謝系は白血球と血小板によってこと
なり、前者の血小板シクロオキシゲナーゼによる代謝系
が機能すると血栓症に移行し、又白血球リポキシゲナー
ゼによる代謝系が機能するとアレルギー反応が発生する
ものである。
In other words, arachidonic acid has two metabolic systems, one by the enzyme cyclooxygenase and the other by the enzyme lipoxygenase, and these metabolic systems differ depending on leukocytes and platelets, and if the former metabolic system by platelet cyclooxygenase functions, it will lead to thrombosis. Also, allergic reactions occur when the metabolic system by leukocyte lipoxygenase functions.

また、リポキシゲナーゼによる代謝系を押さえ血小板シ
クロオキシゲナーゼによる代謝系を活性化させると血栓
症が発現する傾向になる。
Furthermore, if the metabolic system by lipoxygenase is suppressed and the metabolic system by platelet cyclooxygenase is activated, thrombosis tends to occur.

しかもこのアラキドン酸の代謝系はこの2系統しかなく
この血栓症とアレルギーを同時に押さえるという医薬品
は一切なく、勿論食品も無いばかりか、前述の如く血栓
症を予防しすぎるとアレルギー症が発現し、アレルギー
症を予防しすぎると血栓症候群が発現するという誠に困
難な二律背反的な問題があった。
Moreover, there are only two metabolic systems for arachidonic acid, and there are no medicines that can simultaneously suppress thrombosis and allergies.Not only is there no food available, but as mentioned above, if you prevent thrombosis too much, allergies will develop. There was a truly difficult and contradictory problem in that over-prevention of allergic diseases could lead to the development of thrombotic syndrome.

従って、高糖質素、高脂肪食に由来する、肥満症の成人
、児童が増加傾向の近年、この肥満に由来するアレルギ
ー症、動脈硬化症等の血栓症候群が増加しており、この
何れかの症状または、この両方の症状を呈するひとさえ
存在し、アレルギー症、成人病(血栓症候群等)を発現
する前に肥満症の人々(成人及び児童)の弊害を除去す
る予防的食品が、肥満症の人々及び業界においてこのよ
うな肥満症由来の弊害を予防的に回避する食品の創出が
切実に要望されていた。
Therefore, in recent years, as the number of obese adults and children due to high carbohydrate and high fat diets has been increasing, the incidence of thrombotic syndromes such as allergies and arteriosclerosis due to obesity is increasing. There are some people who exhibit symptoms or even both symptoms, and preventive foods that eliminate the harmful effects of obesity in people (adults and children) before they develop allergies and adult diseases (thrombotic syndrome, etc.) are needed to treat obesity. There has been an urgent need among people and industry to create a food product that preventively avoids the harmful effects of obesity.

(発明の経過) そこで、この発明者は上記従来の欠点を悉く解消するた
め鋭意研究したところレンギヨウ及び/又はこの近縁種
を原料とするアレルギー及び成人病予防食品が、何と驚
くべきことに、アレルギー反応及び成人病(各種血栓症
等)を6同時に阻止することを見いだした。
(Progress of the Invention) Therefore, the inventor conducted intensive research to eliminate all of the above-mentioned conventional drawbacks, and surprisingly, an allergy and adult disease preventive food made from Forsythia and/or its related species was discovered. It was found that allergic reactions and adult diseases (such as various thromboses) can be inhibited simultaneously.

その結果、レンギヨウ及び/又はこの近縁種を原料とし
て食品を調製すれば手軽に食品として傾向摂取でき、ア
レルギー及び成人病(各種血栓症等)の予防に大きな効
果があることを見いだし、この発明に至った。
As a result, it was discovered that if a food is prepared using Forsythia and/or its related species as a raw material, it can be easily consumed as a food, and it is highly effective in preventing allergies and adult diseases (such as various thrombosis). reached.

(解決手段) 即ち この発明はレンギヨウ(Forsythia 5
upensa Vahl)及び/又は近縁種を必須成分
としてなるレンギヨウ及び/又はこの近縁種を原料とす
るアレルギー及び成人病予防食品に関する。
(Solution Means) That is, this invention solves the problem of Forsythia 5.
The present invention relates to an allergy and adult disease preventive food made from forsythia and/or its related species as an essential ingredient.

(発明の効果) この発明で使用するレンギヨウとは、モクセイ科(OL
eaceae)に属し、学名をフォルシシア サウペン
サ バール(Forsythia 5upensa V
ahl)という。
(Effect of the invention) Forsythia used in this invention is Oleaceae (OL).
eaceae), and its scientific name is Forsythia 5upensa V.
ahl).

この発明においては、このレンギヨウ(Forsyth
ia 5upensa Vahl)の近縁種例えばシナ
レンギヨウ(Forsythia viridissm
a Lindl)等のモクセイ科の落葉低木の近縁種が
使用できる。
In this invention, this forsyth (Forsyth)
ia 5upensa Vahl), such as Forsythia viridissm
Closely related species of deciduous shrubs of the Oleaceae family, such as A Lindl), can be used.

この発明においては、上記レンギヨウの使用部位として
は、全部位好ましくは成熟果実を乾燥したもの、即ち乾
燥果実を用いる。
In this invention, the whole part of the forsythia is used, preferably the dried mature fruit, that is, the dried fruit.

この発明において、レンギヨウの全部位、望ましくは乾
燥果実からアレルギー及び成人病の予防食品を得るには
、乾燥粉末(凍結乾燥物、熱風乾燥物、天然乾燥物、抽
出乾燥物)、或いは抽出物とすればよい。
In this invention, in order to obtain a preventive food for allergies and adult diseases from all parts of Forsythia, preferably dried fruit, dry powder (lyophilized product, hot air dried product, natural dried product, extracted dried product) or extract is used. do it.

たとえば、抽出物とするにはまずレンギヨウ又はシナレ
ンギヨウの乾燥果実から抽出を行う。
For example, in order to obtain an extract, first extraction is performed from dried fruits of Forsythia or Forsythia.

抽出方法は、熱水抽出又は含酸素系溶剤、アルコール類
、エーテル類、ケトン類、エステル類等、による抽出の
いずれかで行う。
The extraction method is either hot water extraction or extraction with oxygen-containing solvents, alcohols, ethers, ketones, esters, etc.

この発明において、レンギヨウ又はシナレンギヨウ(以
下レンギヨウ等という)の乾燥果実から熱水抽出物を得
るには次のように行う。
In this invention, a hot water extract from the dried fruit of Forsythia or Forsythia (hereinafter referred to as Forsythia etc.) is obtained as follows.

即ち、レンギヨウの乾燥果実を裁断しこの裁断物を1〜
10hr好ましくは5hr60〜80℃好ましくはは7
0℃の熱水に浸漬して、乾燥果実裁断物中の熱水溶性成
分を熱水中に抽出せしめかかる後濾過し、熱水抽出物を
含む濾液を得、同濾液を濃縮し、更に噴霧乾燥して熱水
抽出物を粉末状態で得る。
That is, cut the dried fruit of Forsythia and cut this cut into 1~
10hrs preferably 5hrs 60-80℃ preferably 7
The dried fruit is immersed in hot water at 0°C to extract the hot water-soluble components in the dried fruit cut into the hot water, and then filtered to obtain a filtrate containing the hot water extract.The filtrate is concentrated and further sprayed. Dry to obtain a hot water extract in powder form.

場合によっては濃縮エキスでもよい。Depending on the case, a concentrated extract may be used.

またこの発明においてレンギヨウ等の乾燥果実から含酸
素系有機溶剤による抽出物を得るには次のように行う。
Further, in the present invention, an extract using an oxygen-containing organic solvent from dried fruits such as forsythia can be obtained as follows.

即ちレンギヨウ等の乾燥果実に対して含酸素系有機溶剤
、好ましくはエタノール場合によってはアセトンを加え
て、20〜60℃好ましくは40℃の加熱下で 2〜6
hr好ましくは4hr放置する。またこの場合室温(2
5℃)であれば1昼夜放置しておいてもよい。
That is, an oxygen-containing organic solvent, preferably ethanol, and in some cases acetone is added to dried fruits such as forsythia, and the mixture is heated at 20 to 60°C, preferably 40°C.
Leave for 4 hours, preferably 4 hours. In this case, room temperature (2
5°C), it may be left overnight.

しかし上記レンギヨウ等の乾燥果実中の溶剤可溶成分を
溶剤中に抽出せしめた後、濾過を行い、濾液を濃縮し更
に噴霧乾燥して溶剤抽出物を粉末状態で得る。溶剤抽出
物は、濃縮エキス状のままでもよい。
However, after the solvent-soluble components in dried fruits such as forsythia are extracted into a solvent, filtration is performed, and the filtrate is concentrated and further spray-dried to obtain a solvent extract in the form of a powder. The solvent extract may remain in the form of a concentrated extract.

必要に応じて、以上のようにして得られた熱水抽出物又
は溶剤抽出物をカラムクロマトグラフィーによって精製
する。
If necessary, the hot water extract or solvent extract obtained as described above is purified by column chromatography.

この精製によってレンギヨウ類の抽出物から得られる精
製物(I)がフォルシティサイド[Forsythia
side ] (次式(1))であり、シナレンギヨウ
の乾燥果実の抽出物から得られる精製物(If)がアク
チオサイド[Acteoside ] (次式(2))
である。
Through this purification, the purified product (I) obtained from the extract of Forsythia
side ] (the following formula (1)), and the purified product (If) obtained from the extract of the dried fruit of Psyllium sinensis is acteoside [Acteoside] (the following formula (2))
It is.

以上のようにして得られたレンギヨウ等の、粉末、抽出
物の粉末、濃縮エキス、精製物(I)、(■)からレン
ギヨウ及び/又はこの近縁種を原料とするアレルギー及
び成人病予防食品を得るには、常法に準じて行えばよく
、即ち、菓子、清涼飲料水、主食、散剤、顆粒状に調製
すればよく、必要に応じた増量剤、香味剤、甘味剤、賦
形剤等の添加剤を加えてもよい。
Allergy and adult disease prevention food made from forsythia powder, extract powder, concentrated extract, purified product (I), (■) of forsythia and/or its related species obtained as above. To obtain it, it can be carried out according to conventional methods, that is, it can be prepared into confectionery, soft drinks, staple foods, powders, and granules, and fillers, flavoring agents, sweeteners, and excipients may be added as necessary. You may add additives such as.

又、通常この発明に係るアレルギー及び成人病予防食品
は成人−人当たり、上記レンギヨウ等の粉末換算で50
0〜10000■好ましくは1000■程度喫食できる
よう調製すればよい。
In addition, the allergy and adult disease preventive food according to the present invention usually contains 50 ml of the above-mentioned forsythia powder per adult.
It may be prepared so that it can be eaten from 0 to 10,000 square meters, preferably about 1,000 square meters.

(発明の効果) 以上のようにレンギョ、つ及び/又はこの近縁種から抽
出された抽出物を必須成分としてなるレンギヨウ及び/
又はこの近縁種を原料とするアレルギー及び成人病予防
食品は、医薬でないので家庭で手軽に用いられことに加
え、従来全く不可能であったアレルギー及び血栓症等の
成人病の両者を有効に防止できるという効果を奏する。
(Effects of the Invention) As described above, forsythia and/or forsythia containing extracts extracted from forsythia and/or its related species are essential ingredients.
Foods for preventing allergies and adult diseases made from this closely related species are not only non-medicinal, so they can be easily used at home, and can also be used to effectively treat both allergies and adult diseases such as thrombosis, which was previously impossible. It has the effect of being able to prevent this.

以下、この発明に係るレンギヨウ及び/又はこの近縁種
を原料とするアレルギー及び成人病予防食品の実施例、
実験例を記載することによりこの発明の効果を一層明確
なものにする。
Examples of the allergy and adult disease preventive food made from forsythia and/or its related species according to the present invention are as follows:
The effects of this invention will be made clearer by describing experimental examples.

(実施例1) レンギヨウの乾燥果実を裁断し、この裁断物1000g
を5hr 、 70℃の熱水31に浸漬して乾燥果実中
の熱水溶性成分を熱水中に抽出せしめ、かかる後濾過し
熱水抽出物を含む濾液を得、同濾液を濃縮し、更に噴霧
乾燥して熱水抽出物を粉末状態で得た。
(Example 1) Dried forsythia fruit was cut, and 1000 g of the cut material was cut.
The dried fruit was immersed in hot water 31 at 70°C for 5 hours to extract the hot water-soluble components in the dried fruit, and then filtered to obtain a filtrate containing the hot water extract, and the filtrate was concentrated, and further A hot water extract was obtained in powder form by spray drying.

この熱水抽出物の粉末をカラムクロマトグラフィーによ
り精製して、レンギヨウの熱水抽出物から精製物(I)
、フォルシティアサイド、シナレンギヨウの抽出物から
精製物(n)アクチオサイドを得た。
The powder of this hot water extract was purified by column chromatography to obtain purified product (I) from the hot water extract of Forsythia
Purified product (n) actioside was obtained from extracts of , Forsitiaside, and Cinnamon.

この精製物(1)、(n)各々500■果糖を加えて一
包3gの散剤として調製し、アレルギー及び成人病予防
食品とした。
500 μg of fructose was added to each of the purified products (1) and (n) to prepare a powder of 3 g per package, which was used as a food for preventing allergies and adult diseases.

(実施例2) シナレンギヨウの乾燥果実を裁断し、この裁断物中50
0gに51のエタノールを加えて、40℃の加熱下で4
hr放置しレンギヨウ等の乾燥果実中のエタノール可溶
成分をエタレール中に抽出せしめた後、濾過を行い、濾
液を抽出し、更に噴霧乾燥してエタノール抽出物を粉末
エキス状態で得る。
(Example 2) Dried fruits of Psyllium were cut into pieces, and 50% of the cut pieces were
Add 51 ethanol to 0g and heat at 40°C.
After leaving for hours to extract the ethanol-soluble components in dried fruits such as forsythia into etaler, filtration is performed, the filtrate is extracted, and the fruit is further spray-dried to obtain an ethanol extract in the form of a powder extract.

この粉末エキスをカラムクロマトグラフィーにより精製
し、レンギヨウのエタノール抽出物から精製物(I)フ
ォルシティアサイド、シナレンギヨウのエタノール抽出
物から精製物(n)アクチオサイドを得た。
This powder extract was purified by column chromatography to obtain purified product (I) forsitiaside from the ethanol extract of Forsythia, and purified product (n) actioside from the ethanol extract of Forsythia.

この精製物(1)、(I[)各々500 mgに各々果
糖を加えて一包3gの散剤として調製し、アレルギー及
び成人病予防食品とした。
Fructose was added to 500 mg of each of the purified products (1) and (I[) to prepare a powder of 3 g per package, which was used as a food for preventing allergies and adult diseases.

(試験例1) ウィスター系♂ラフトを使用し、このラット腹腔内多核
白血球をHE P S−生食緩衝液(PH7,4)で洗
浄し、同緩衝液に懸濁、超音波処理を行ったものをアラ
キドン酸代謝の酵素液として用いた。この血小板ホモシ
ネイトとフォルシティアサイド(For−sy−thi
a 5ide)及びアクチオサイド(Acteosid
e)の次表にそれぞれ示す種々の濃度のサンプルとを3
7℃5分間保温し、その後[1−C]アラキドン酸(0
,05μci)を加え5分間インキュベイトした。
(Test Example 1) Wistar male rafts were used, and the rat intraperitoneal polynuclear leukocytes were washed with HEPS-saline buffer (PH7,4), suspended in the same buffer, and subjected to ultrasound treatment. was used as an enzyme solution for arachidonic acid metabolism. This platelet homocynate and forsythiaside (For-sy-thi)
a 5ide) and acteoside (Acteosid
e) with various concentrations shown in the following table.
Incubate at 7°C for 5 minutes, then add [1-C] arachidonic acid (0
, 05 μci) and incubated for 5 minutes.

反応をギ酸で止め(ph3)アラキドン酸代謝物を酢酸
エチルで抽出し、シリカゲル薄層クロマトグラフィー(
TL(3)で分離して定量した(展開液:酢酸エチル:
 2.2.4−トリメチルペンタン:酢酸:水=100
:50:20:100.V/V、上層、TLCはメ/L
/り574B)。
The reaction was stopped with formic acid (pH 3), and arachidonic acid metabolites were extracted with ethyl acetate and subjected to silica gel thin layer chromatography (
It was separated and quantified using TL (3) (developing solution: ethyl acetate:
2.2.4-Trimethylpentane:acetic acid:water=100
:50:20:100. V/V, upper layer, TLC is me/L
/ri574B).

放射活性物質はオートラジオグラフィで検出し、そのス
ポットを切取り、放射活性を液体シンチレーションカウ
ンターで定量した。
Radioactive substances were detected by autoradiography, the spots were cut out, and radioactivity was quantified using a liquid scintillation counter.

結果を第1表乃至第4表にまとめて示す。The results are summarized in Tables 1 to 4.

(以下余白) 第1表 ※フォルシティアサイドの単位は1モル×10の慕指数 ※※濃度0の比較例 第2表 ※アクチオサイドの単位は1モル×10の粟指数※※濃
度Oの比較例 第3表 ※フォルシティアサイドの単位は1モル×10の慕指数 ※※濃度Oの比較例 第4表 ※アクチオサイドの単位は1モシレ×10の粟指数※※
濃度Oの比較例 以上の結果から明らかなように、レンギヨウ又はシナレ
ンギヨウから抽出された抽出物を精製したフォルシティ
アサイド(Forsythiaside)又はアクチオ
サイド(Acteoside)は5−HETEの生成を
阻害すると共に6−Keto−PGFI cx (PC
l3の分解物)の生成を向上させるものであり、即ちレ
ンギヨウ又はシナレンギヨウから抽出された抽出物を必
須成分としてなる健康食品は、アレルギー及び成人病(
各種血栓症等)の治療に優れた効果を奏することがわか
る。
(Leaving space below) Table 1 *The unit of forsithiaside is 1 mol x 10 millet index ※Comparative example at concentration 0 Table 2 *The unit of actioside is 1 mol x 10 millet index ※Comparative example of concentration O Table 3 *The unit of forsitiaside is the millet index of 1 mole x 10 ※※Comparison example of concentration O Table 4 *The unit of actioside is the millet index of 1 mole x 10**
Comparative Example of Concentration O As is clear from the above results, forsythiaside or acteoside, which is purified extract from Forsythia forsythia or Forsythia forsythia, inhibits the production of 5-HETE and also inhibits the production of 6-Keto. -PGFI cx (PC
In other words, health foods containing extracts extracted from Forsythia or Forsythia as an essential ingredient are effective in preventing allergies and adult diseases (
It can be seen that it has an excellent effect on the treatment of various types of thrombosis, etc.).

(試験例2) 肥満症の男女20人をそれぞれ2群に分け、第1群に実
施例1の散剤を、第2群に実施例2の散在を朝晩1包み
づつ喫食させ、4週間後の血圧低下度及びアレルギー症
候(接触性アレルギー)についてみた。
(Test Example 2) Twenty obese men and women were divided into two groups, and the first group was given the powder of Example 1, and the second group was given one packet of the powder of Example 2 in the morning and evening. We looked at the degree of blood pressure drop and allergic symptoms (contact allergy).

接触性アレルギーは、刺激性香料をバ・ッチテストで行
った。
Contact allergy was determined using the Ba-ch test against irritating fragrances.

試験前の状態を第5表に、4週間後の結果を第6表に示
す。
The conditions before the test are shown in Table 5, and the results after 4 weeks are shown in Table 6.

第5表 第6表Table 5 Table 6

Claims (3)

【特許請求の範囲】[Claims] (1)レンギョウ(Forsythia supens
a Vahl)及び/又は近縁種を必須成分としてなる
レンギョウ及び/又はこの近縁種を原料とするアレルギ
ー及び成人病予防食品。
(1) Forsythia supens
An allergy and adult disease preventive food made from forsythia and/or its related species as an essential ingredient.
(2)レンギョウ(Forsythia supens
a Vahl)及び/又は近縁種が、その乾燥物及び/
又は抽出物であることを特徴としてなる特許請求の範囲
第(1)項記載のレンギョウ及び/又はこの近縁種を原
料とするアレルギー及び成人病予防食品。
(2) Forsythia supens
a Vahl) and/or related species in its dried form and/or
The allergy and adult disease preventive food made from forsythia and/or its closely related species according to claim (1), characterized in that it is a forsythia or an extract thereof.
(3)前記レンギョウ(Forsythia supe
nsa Vahl)及び/又は近縁種から抽出された抽
出物が次式( I )及び/又は(II)であることを特徴
とする特許請求の範囲第(1)項又は第(2)項記載の
レンギョウ及び/又はこの近縁種を原料とするアレルギ
ー及び成人病予防食品。 ▲数式、化学式、表等があります▼・・・( I ) ▲数式、化学式、表等があります▼・・・(II)
(3) Forsythia supe
Claims (1) or (2), characterized in that the extract extracted from the following formula (I) and/or (II) Allergy and adult disease preventive food made from forsythia and/or its related species. ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(II)
JP60133784A 1985-06-19 1985-06-19 Food for preventing allergy and adult disease and produced from rengyo and/or related species thereof Pending JPS61291525A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60133784A JPS61291525A (en) 1985-06-19 1985-06-19 Food for preventing allergy and adult disease and produced from rengyo and/or related species thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60133784A JPS61291525A (en) 1985-06-19 1985-06-19 Food for preventing allergy and adult disease and produced from rengyo and/or related species thereof

Publications (1)

Publication Number Publication Date
JPS61291525A true JPS61291525A (en) 1986-12-22

Family

ID=15112916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60133784A Pending JPS61291525A (en) 1985-06-19 1985-06-19 Food for preventing allergy and adult disease and produced from rengyo and/or related species thereof

Country Status (1)

Country Link
JP (1) JPS61291525A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394837A2 (en) * 1989-04-20 1990-10-31 San-A Pharmaceutical Co., Ltd Feed additive for cultivated fishes and feed for cultivated fishes
FR2652086A1 (en) * 1989-09-20 1991-03-22 Andary Claude New compound of plant origin, derived from caffeic acid, oraposide; composition for therapeutic use and dermocosmetic composition containing it
JP2005082546A (en) * 2003-09-10 2005-03-31 Kanebo Cosmetics Inc alpha-GLUCOSIDASE INHIBITOR
JP2006306791A (en) * 2005-04-28 2006-11-09 Kanebo Cosmetics Inc Hair growth-stimulating agent
JP2012106945A (en) * 2010-11-16 2012-06-07 Nof Corp Histamine release inhibitor
CN104435429A (en) * 2014-11-30 2015-03-25 孙晓兵 Traditional Chinese medicine composition for treating anaphylactoid purpura

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152323A (en) * 1983-02-08 1984-08-31 Moriyuki Hiramatsu Fomentation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152323A (en) * 1983-02-08 1984-08-31 Moriyuki Hiramatsu Fomentation

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394837A2 (en) * 1989-04-20 1990-10-31 San-A Pharmaceutical Co., Ltd Feed additive for cultivated fishes and feed for cultivated fishes
FR2652086A1 (en) * 1989-09-20 1991-03-22 Andary Claude New compound of plant origin, derived from caffeic acid, oraposide; composition for therapeutic use and dermocosmetic composition containing it
JP2005082546A (en) * 2003-09-10 2005-03-31 Kanebo Cosmetics Inc alpha-GLUCOSIDASE INHIBITOR
JP2006306791A (en) * 2005-04-28 2006-11-09 Kanebo Cosmetics Inc Hair growth-stimulating agent
JP2012106945A (en) * 2010-11-16 2012-06-07 Nof Corp Histamine release inhibitor
CN104435429A (en) * 2014-11-30 2015-03-25 孙晓兵 Traditional Chinese medicine composition for treating anaphylactoid purpura

Similar Documents

Publication Publication Date Title
Policegoudra et al. Antimicrobial, antioxidant, cytotoxicity and platelet aggregation inhibitory activity of a novel molecule isolated and characterized from mango ginger (Curcuma amada Roxb.) rhizome
US20010020009A1 (en) Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
JP2008526834A (en) Use of lignan compounds for the treatment or prevention of inflammatory diseases
Kumar et al. Antioxidant and free radical scavenging activities of edible weeds
KR20160050108A (en) Compositions for Improving Oral Hygiene comprising extracts derived from natural materials and Uses Thereof
JPS61171427A (en) Substance for preventing thrombosis or the like
WO2016159593A9 (en) Pharmaceutical composition for preventing or treating inflammatory diseases, containing lactococcus chungangensis as active ingredient
JP2946183B2 (en) Perilla extract having TNF production inhibitory action
JPS61291525A (en) Food for preventing allergy and adult disease and produced from rengyo and/or related species thereof
JP5467795B2 (en) β-secretase inhibitor
JP2005213178A (en) TNF-alpha PRODUCTION INHIBITOR, ESTROGENIC AGENT AND EXTERNAL PREPARATION FOR SKIN
JP2008156265A (en) A-type proanthocyanidin oligomer fraction and method for producing the same
JP4169244B2 (en) Antiallergic agent and method for producing the same
KR20210066089A (en) Composition for Anti-inflammation Using an Extract of Lemon Peel and a Root Extract of Sophora flavescens
JP3977889B2 (en) Drugs containing buckwheat husk extract as an active ingredient
KR101982657B1 (en) Composition for Anti-inflammation Using an Extract of Tetracera loureiri
JPH04298501A (en) Polysaccharide composition or polysaccharide having heparinoid activity, production thereof and anticoagulant containing same as active ingredient
JPH0881380A (en) Anti-periodontitis agent and anti-periodontitis food containing high-molecular weight polyphenol as active component
JPS5838208A (en) Tannin-containing composition for oral cavity
JP4708744B2 (en) Platelet aggregation inhibitory composition
JPH03157330A (en) Antiallergic agent
JP3455436B2 (en) How to make antioxidants
JPH10287582A (en) Suppressant for liberation of histamine comprising bark extract
KR101270525B1 (en) Composition for preventing and treating of pulmonary emphysema and pulmonary hypertension, comprising an extract of Albizziae Cortex as an effective component
KR102668013B1 (en) Anti-inflammatory Composition Using (1R,4S,6S)-1,6-dihydroxy-2-menthene